What are the signs and symptoms of transplant rejection?
Signs and symptoms of transplant rejection include fever, fatigue, joint pain, swelling or tenderness at the transplant site, increased blood pressure, sudden weight gain, reduced urine output, and abnormal lab results indicating organ dysfunction, such as elevated creatinine for kidney transplants.
How is transplant rejection diagnosed?
Transplant rejection is diagnosed through a combination of clinical evaluation, laboratory tests (such as blood tests for markers of organ function), imaging studies, and often a biopsy of the transplanted organ to detect signs of rejection, like inflammatory cell infiltrates or tissue damage.
How can transplant rejection be prevented?
Transplant rejection can be prevented by using immunosuppressive medications to inhibit the immune response, ensuring proper matching of donor and recipient tissue types, and conducting regular monitoring for early signs of rejection. Adhering to prescribed medication regimens and follow-up appointments with healthcare providers are critical for successful transplant outcomes.
What treatments are available for transplant rejection?
Treatments for transplant rejection include immunosuppressive medications such as corticosteroids, calcineurin inhibitors (e.g., cyclosporine, tacrolimus), antimetabolites (e.g., azathioprine, mycophenolate mofetil), and monoclonal antibodies (e.g., basiliximab, alemtuzumab). Adjusting the dosage or switching medications may also be necessary.
What factors increase the risk of transplant rejection?
Factors that increase the risk of transplant rejection include genetic differences between donor and recipient, inadequate immunosuppression, pre-existing antibodies in the recipient, history of previous transplant rejections, non-adherence to medication, and infections that activate the immune system.